This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sharma, R. A. Articles by Gescher, A. Search for Related Content PubMed PubMed Citation Articles by Sharma, R. A. Articles by Gescher, A.

Effects of Dietary Curcumin on Glutathione S-Transferase and Malondialdehyde-DNA Adducts in Rat Liver and Colon Mucosa

Relationship with Drug Levels¹

Department of Oncology [R. A. S., K. A. H., M. L. W., W. P. S.] and MRC Centre for Mechanisms of Human Toxicity [C. R. I., R. D. V., C. L., M. M. M., A. G.], University of Leicester, Leicester LE1 9HN, Untied Kingdom, and Vanderbilt Cancer Center, Nashville, Tennessee 37232 [L. J. M.]

Curcumin prevents colon cancer in rodent models. It inhibits lipid peroxidation and cyclooxygenase-2 (COX-2) expression and induces glutathione S-transferase (GST) enzymes. We tested the hypothesis that 14 days of dietary curcumin (2%) affects biomarkers relevant to cancer chemoprevention in the rat. Levels of inducible COX-2, as reflected by prostaglandin E₂ production by blood leukocytes, were measured ex vivo. Total GST activity and adducts of malondialdehyde with DNA (M₁G), which reflect endogenous lipid peroxidation, were measured in colon mucosa, liver, and blood leukocytes. Curcumin and its metabolites were analyzed by high-performance liquid chromatography in plasma, and its pharmacokinetics were compared following a diet containing 2% curcumin versus intragastric (i.g.) administration of curcumin suspended in an amphiphilic solvent. The curcumin diet did not alter any of the markers in the blood but increased hepatic GST by 16% and decreased colon M₁G levels by 36% when compared with controls. Administration of carbon tetrachloride during the treatment period increased colon M₁G levels, and this increase was prevented by dietary curcumin. Dietary curcumin yielded low drug levels in the plasma, between 0 and 12 nM, whereas tissue concentrations of curcumin in liver and colon mucosa were 0.1–0.9 nmol/g and 0.2–1.8 µmol/g, respectively. In comparison with dietary administration, suspended curcumin given i.g. resulted in more curcumin in the plasma but much less in the colon mucosa. The results show that curcumin mixed with the diet achieves drug levels in the colon and liver sufficient to explain the pharmacological activities observed and suggest that this mode of administration may be preferable for the chemoprevention of colon cancer.

This article has been cited by other articles:

				S. K. Vareed, M. Kakarala, M. T. Ruffin, J. A. Crowell, D. P. Normolle, Z. Djuric, and D. E. Brenner Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1411 - 1417. [Abstract] [Full Text] [PDF]

				R. Garg, S. Gupta, and G. B. Maru Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[a]pyrene-treated mice: mechanism of its anti-initiating action Carcinogenesis, May 1, 2008; 29(5): 1022 - 1032. [Abstract] [Full Text] [PDF]

				S. Shankar and R. K. Srivastava Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa Carcinogenesis, June 1, 2007; 28(6): 1277 - 1286. [Abstract] [Full Text] [PDF]

				J. Cao, L. Jia, H.-M. Zhou, Y. Liu, and L.-F. Zhong Mitochondrial and Nuclear DNA Damage Induced by Curcumin in Human Hepatoma G2 Cells Toxicol. Sci., June 1, 2006; 91(2): 476 - 483. [Abstract] [Full Text] [PDF]

				D. Chirnomas, T. Taniguchi, M. de la Vega, A. P. Vaidya, M. Vasserman, A.-R. Hartman, R. Kennedy, R. Foster, J. Mahoney, M. V. Seiden, et al. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol. Cancer Ther., April 1, 2006; 5(4): 952 - 961. [Abstract] [Full Text] [PDF]

				S. Bengmark Curcumin, An Atoxic Antioxidant and Natural NF{kappa}B, Cyclooxygenase-2, Lipooxygenase, and Inducible Nitric Oxide Synthase Inhibitor: A Shield Against Acute and Chronic Diseases JPEN J Parenter Enteral Nutr, January 1, 2006; 30(1): 45 - 51. [Abstract] [Full Text] [PDF]

				Y.-C. Jeong, J. Nakamura, P. B. Upton, and J. A. Swenberg Pyrimido[1,2-a]-purin-10(3H)-one, M1G, is less prone to artifact than base oxidation Nucleic Acids Res., November 10, 2005; 33(19): 6426 - 6434. [Abstract] [Full Text] [PDF]

				G. P. Collett and F. C. Campbell Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells Carcinogenesis, November 1, 2004; 25(11): 2183 - 2189. [Abstract] [Full Text] [PDF]

				R. A. Sharma, S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan, D. Hemingway, S. M. Plummer, et al. Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance Clin. Cancer Res., October 15, 2004; 10(20): 6847 - 6854. [Abstract] [Full Text] [PDF]

				Y. Song, N. D. Sonawane, D. Salinas, L. Qian, N. Pedemonte, L. J. V. Galietta, and A. S. Verkman Evidence against the Rescue of Defective {Delta}F508-CFTR Cellular Processing by Curcumin in Cell Culture and Mouse Models J. Biol. Chem., September 24, 2004; 279(39): 40629 - 40633. [Abstract] [Full Text] [PDF]

				P. J. Moos, K. Edes, J. E. Mullally, and F. A. Fitzpatrick Curcumin impairs tumor suppressor p53 function in colon cancer cells Carcinogenesis, September 1, 2004; 25(9): 1611 - 1617. [Abstract] [Full Text] [PDF]

				M. Brink, M. P. Weijenberg, A. F. P. M. de Goeij, L. J. Schouten, F. D. H. Koedijk, G. M. J. M. Roemen, M. H. F. M. Lentjes, A. P. de Bruine, R.A. Goldbohm, and P. A. van den Brandt Fat and K-ras mutations in sporadic colorectal cancer in The Netherlands Cohort Study Carcinogenesis, September 1, 2004; 25(9): 1619 - 1628. [Abstract] [Full Text] [PDF]

				N. K. Basu, M. Ciotti, M. S. Hwang, L. Kole, P. S. Mitra, J. W. Cho, and I. S. Owens Differential and Special Properties of the Major Human UGT1-encoded Gastrointestinal UDP-glucuronosyltransferases Enhance Potential to Control Chemical Uptake J. Biol. Chem., January 9, 2004; 279(2): 1429 - 1441. [Abstract] [Full Text] [PDF]

				J. W Lampe Spicing up a vegetarian diet: chemopreventive effects of phytochemicals Am. J. Clinical Nutrition, September 1, 2003; 78(3): 579S - 583. [Abstract] [Full Text] [PDF]

				L. J. Niedernhofer, J. S. Daniels, C. A. Rouzer, R. E. Greene, and L. J. Marnett Malondialdehyde, a Product of Lipid Peroxidation, Is Mutagenic in Human Cells J. Biol. Chem., August 15, 2003; 278(33): 31426 - 31433. [Abstract] [Full Text] [PDF]

				S. Perkins, R. D. Verschoyle, K. Hill, I. Parveen, M. D. Threadgill, R. A. Sharma, M. L. Williams, W. P. Steward, and A. J. Gescher Chemopreventive Efficacy and Pharmacokinetics of Curcumin in the Min/+ Mouse, a Model of Familial Adenomatous Polyposis Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 535 - 540. [Abstract] [Full Text] [PDF]

				S. M. Plummer, K. A. Hill, M. F. W. Festing, W. P. Steward, A. J. Gescher, and R. A. Sharma Clinical Development of Leukocyte Cyclooxygenase 2 Activity as a Systemic Biomarker for Cancer Chemopreventive Agents Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1295 - 1299. [Abstract] [Full Text] [PDF]

				R. A. Sharma, A. Gescher, J. P. Plastaras, C. Leuratti, R. Singh, B. Gallacher-Horley, E. Offord, L. J. Marnett, W. P. Steward, and S. M. Plummer Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells Carcinogenesis, September 1, 2001; 22(9): 1557 - 1560. [Abstract] [Full Text] [PDF]